zoe茜813 2021-09-14 15:47 IP:台州
购买 药物警戒系统主文件+药物警戒计划 模板   [更多]
悬赏:
悬赏
¥100.00
已托管
载入中...
zoe茜813 2021-10-01 11:49 IP:台州
求购 药物警戒质量管理规范SOP及药物警戒主文件,请提供详细版,感谢!   [更多]
悬赏:
悬赏
¥100.00
已托管
载入中...
happy196531 2018-04-03 10:20 IP:南京
标题信息: 1、nis SE, Blau LM, Bohne WH. An examination of the injection to scanning interval with 18F and 85Sr. J Can Assoc Radiol 1974; 25: 184-192. 2、lau M, Nagler W, Bender MA. A new isotope for bone scanning. J Nucl Med 1962; 3: 332-334. 3、etren-Mallmin M. Clinical and experimental imaging of breast cancer metastases in the spine. Acta Radiol Suppl 1994; 391: 1-23 要求:上传符合信息的PDF,先到先得   [更多]
悬赏:
悬赏
¥51.00
已托管
载入中...
happy196531 2017-08-11 15:24 IP:南京
文献名称: 1.GI highlights from the literature 2.氯吡格雷活性代谢物合成路线研究 3. H Liehr , WD Heine.Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.Hepato-gastroenterology , 1981 , 28 (6) :296-8 4.N Ebner.Lactose and lactose-derivative (Laevolac) in the treatment of the endogenic factor in parodontopathies.《Osterr Z Stomatol》 , 1973 , 70 (9) :317-324 5.N Ebner.Guidelines for Laevolac therapy against the endogenous factor in periodontal diseases.《Osterr Z Stomatol》 , 1978 (9) :327-331 要求: 1.需要下载到文献全文的PDF版本,以文献原始名称命名。 2.按照合格交稿的顺序,先到先得,一篇文章可以获得10元奖励   [更多]
悬赏:
悬赏
¥100.00
已托管
载入中...
Like2291 2019-04-28 15:40 IP:重庆
1.丙氨酰谷氨酰胺及其注射液的研究开发 2.A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study). Cimminiello C, Arpaia G, Polo Friz H, Boracchi P, Marano G, Spezzigu G, Visonà A. Vasa. 2015 Sep;44(5):371-9. doi: 10.1024/0301-1526/a000456. 3.2013 International Conference on Materials Engineering, ICMEN 2013 4.Orientation of substitution in the aromatic series. XVIII. Sulfonation of phenol by chlorosulfonic acid in solvents 5.Mechanism of reaction of chlorosulfonic acid with some aromatic compounds 6.Arzneimittelforschung. 1982;32(3):248-51. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing. 7.Oral treatment with the Crataegus special extract WS 1442 inhibits cardiac hypertrophy in rats with DOCA-salt or aortic banding induced hypertension   [更多]
悬赏:
悬赏
¥70.00
已托管
载入中...
Dc没_有H 2022-02-18 10:49 IP:广安
盐酸莫西沙星质量标准YBH02632018、YBH03002018、YBH03012018   [更多]
悬赏:
悬赏
¥150.00
已托管
载入中...
霹雳娃 2016-11-28 09:01 IP:呼和浩特
1. EP9, 2.2.23. Atomic absorption spectrometry.......37 2. EP9, 5.10. Control of impurities in substances for pharmaceutical use.....723   [更多]
悬赏:
悬赏
¥20.00
已托管
载入中...
tjq885555 2020-09-02 16:39 IP:南宁
具体要求: 办理第一类医疗器械产品备案所需材料: 1、第一类医疗器械备案表 2.产品风险分析资料 3.产品技术要求 4.产品检验报告 5.临床评价资料 6.生产制造信息 7.产品说明书及最小销售单元标签设计样稿 8.证明性文件 9.符合性声明   [更多]
悬赏:
悬赏
¥200.00
已托管
载入中...
cuiyj12 2021-07-26 11:12 IP:北京
求问在药企实践中,临床试验过程中试验者的个人信息用于不良反应处理和理赔,需要签署知情同意书吗?   [更多]
悬赏:
悬赏
¥100.00
已托管
载入中...
云隐散霾 2015-06-04 10:12 IP:重庆
因涉及保密工作,请有意的个人私聊,不提倡团队接这个任务。   [更多]
悬赏:
悬赏
¥10.00
已托管
载入中...
发布需求,坐等药智客上门
  • 安全可靠,先验收再正式付款
  • 性价比超高,节省一半费用
  • 80%的需求得到了圆满解决
立即发布需求

推荐任务